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ABSTRACT
Forensic and ancient DNA (aDNA) extracts are
mixtures of endogenous aDNA, existing in more
or less damaged state, and contaminant DNA. To
obtain the true aDNA sequence, it is not sufficient
to generate a single direct sequence of the mixture,
even where the authentic aDNA is the most abundant
(e.g. 25% or more) in the component mixture. Only
bacterial cloning can elucidate the components of
this mixture. We calculate the number of clones
that need to be sampled (for various mixture ratios)
in order to be confident (at various levels of confid-
ence) to have identified the major component. We
demonstrate that to be .95% confident of identify-
ing the most abundant sequence present at 70%
in the ancient sample, 20 clones must be sampled.
We make recommendations and offer a free-access
web-based program, which constructs the most
reliable consensus sequence from the user’s input
clone sequences and analyses the confidence
limits for each nucleotide position and for the
whole consensus sequence. Accepted authentica-
tion methods must be employed in order to assess
the authenticity and endogeneity of the result-
ing consensus sequences (e.g. quantification and
replication by another laboratory, blind testing,
amelogeninsexversusmorphologicalsex,theeffect-
ive use of controls, etc.) and determine whether they
are indeed aDNA.
INTRODUCTION
Ancient DNA (aDNA) template is commonly a mixture of
molecules comprising varying amounts of the correct endo-
genous sequence, damaged endogenous sequence, contamin-
ant sequence and damaged contaminant sequence. Therefore,
PCR products from aDNA template are also likely to be a
mixture of misampliﬁed damaged template and contaminant
template. Although protein analysis, amino acid racemization
and DNA quantiﬁcation can act as a proxy for assessing DNA
survival in the starting template, there are currently no effect-
ive methods for assessing the resulting template mixture prior
to PCR.
Thus, the sequencing of individual PCR products, which
have been ligated into a suitable vector and transformed into a
bacterial host (i.e. bacterial cloning), has been put forward as
an essential step by which we can identify the extent and
components of aDNA template mixture (i.e. by sequencing
many clones, each corresponding to a single molecule in the
PCR product mixture). A consensus can then be constructed
from the selected clone sequences once data from possible
jumping PCR events have been identiﬁed and removed. But
how many bacterial clones do we need to sequence for this
consensus to be a reliable representation of the most abundant
sequence?
The exact number of clones necessary to achieve a given
level of conﬁdence in the consensus depends on the frequency
of each incorrect nucleotide at any given nucleotide position in
the sequence. In this paper, we model ways to help researchers
choose the number of clones they need to sequence to obtain
the most representative consensus sequences (i.e. the most
abundant sequence in the template mixture) in the presence
of template mixture (i.e. the presence of contaminating DNA
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Additionally, we launch a web-based tool (the Consensus
Conﬁdence program, which can be found at http://www.
mcdonald.cam.ac.uk) to help researchers assess conﬁdence
levels in their consensus sequences and decide how many
additional clones, if any, they will need to sequence to reach
acceptable conﬁdence levels (e.g. 95% conﬁdence that the
consensus sequence they have constructed is the most abund-
ant sequence present in their aDNA template mixture).
The Consensus Conﬁdence program assesses the quality of
the consensus sequence derived from a given PCR, it does not
verify whether the consensus sequence is authentic aDNA
and cannot replace the use of standard aDNA authentication
methods. Accepted authentication methods must be employed
in order to assess the authenticity and endogeneity of the
resulting consensus sequences (e.g. quantiﬁcation and repli-
cation by another laboratory, blind testing, amelogenin sex
versus morphological sex, the effective use of controls, etc.)
and determine whether they are indeed aDNA.
Sources and consequences of template mixture
There are several points at which template mixture can occur:
during post-depositional decay processes (e.g. diagenesis of
DNA molecular structure following the death and burial of the
organism), excavation and post-excavation events (e.g. hand-
ling by archaeologists and museum staff) and more rarely,
providing that standard aDNA laboratory protocols are fol-
lowed, laboratory processing (e.g. extraction and ampliﬁcation
of DNA). Quantifying same-species contamination of fossil
human remains is a colossal challenge (1), but even when
working with non-human template, contamination from DNA
of the same species cannot be ruled out, e.g. where research
materialisderived frommuseum collectionsorwherereagents
or plasticware are contaminated during manufacture (2).
Pre-laboratory and laboratory contamination can be greatly
reduced by following established protocols, i.e. effective and
informative controls and contamination avoidance strategies
(3). However, several authors have demonstrated that, in some
cases, even the most stringent controls can fail to prevent or
detect low-level contamination (1).
Cloning of PCR products is currently the only way of effect-
ively elucidating the extent of contamination type mixture.
However, even without taking contamination into account
aDNA template is a mixture of individual DNA molecules,
which contain differing levels of damage (e.g. depurination,
deamination, strand breakage, cross-linking, etc.) according to
their micro-taphonomic history. Some forms of DNA damage
prevent PCR ampliﬁcation altogether (e.g. strand breakage
and cross-linking); however, where ampliﬁcation of damaged
DNA molecules is possible, it can result in misincorporation
of nucleotides during PCR (4,5) and is probably the most
common source of incorrect nucleotide in any given sequence.
These misincorporations can be signiﬁcant at any nucleotide
position, and particularly so if they occur at nucleotide posi-
tions where phylogenetic variation is expected as this can
affect subsequent analysis (6).
It has been argued that direct sequencing minimizes
the chance of detecting sequences of minor contaminants
or of ampliﬁcation errors (7,8). This argument may apply in
particular circumstances where external evidence is sufﬁ-
ciently strong to validate the direct sequence (9). In less ideal
circumstances, cloning is necessary (1,5,10–16). A consensus
derived by direct sequencing could differ from the true aDNA
sequence, in particular when the true sequence constitutes
<50% of the mixture. Sequencing a number of clones, on
the other hand, can reveal the most abundant nucleotide at
a position so long as that nucleotide occurs in >25% of clones.
Further standard authentication criteria must then be applied
(17–20) to determine whether the most abundant nucleotide is
plausibly the true aDNA. If it can be assumed that the most
abundant nucleotide is also the true aDNA nucleotide (e.g. by
fulﬁlling all other standard authentication criteria), then the
true ancient nucleotide can be ascertained with a quantiﬁable
degree of conﬁdence.
METHODS
To calculate the number of cloned bacterial colonies to
sequence, we take a random sample of n DNA molecules
from a population of molecules with known proportions,
where 1 nt is correct (with proportion PC) and the other three
represent contamination, damage or PCR errors (with propor-
tions PI1, PI2 and PI3). The probability of drawing a sample of
S = (j, k, l, m) molecules from the population of molecules is
the multinomial
PS ðÞ ¼
n!
j!k!l!m!
P
j
C Pk
I1 Pl
I2 Pm
I3: 1
For a given sample, we deﬁne the consensus choice as the
most abundant nucleotide in the sample, with ties broken at
random. Breaking ties at random means that if there are two
mostabundantnucleotides inthe sample,we willchoose either
one with equal probability. We assume that there is only one
most abundant nucleotide in the population, which is reason-
able if the population (e.g. the set of all molecules present after
the ﬁnal round of PCR) is large enough to treat proportions as
continuous. We also deﬁne the representative consensus as the
nucleotide that is most abundant in the population. Then the
probability that we will choose the representative consensus
nucleotide is
DS ðÞ ¼
d j‚ max j‚k‚l‚m ðÞ ðÞ
P
s2S d s‚ max j‚k‚l‚m ðÞ ðÞ
‚ 2
where d is the Kronecker delta function,
d j‚ max j‚k‚l‚m ðÞ ðÞ ¼
1‚ if j ¼ max j‚k‚l‚m ðÞ ‚
0‚ otherwise:
 
Putting together Equations 1 and 2 and summing over all
possible samples, the probability of getting the representative
consensus is
P correct consensus ðÞ ¼
X n
j¼0
X n j
k¼0
X n j k
l¼0
PS ðÞ DS ðÞ 3
withm=n j k l.Solongasthecorrectnucleotideismore
frequent than any other (even if it constitutes <50%), the
probability ofobtainingarepresentativeconsensusapproaches
1 as the number of molecules sampled becomes large.
2550 Nucleic Acids Research, 2005, Vol. 33, No. 8When determining a representative consensus over an
entire experiment, we do not distinguish between clones
from single extractions and clones from multiple extractions.
The latter design would perhaps be more appropriate, as
repeated extractions and PCRs, which continuously give the
same result, would additionally increase our conﬁdence that a
sequence is endogenous. However, this is impossible to model
mathematically.
RESULTS
We used Equation 3 to calculate the probability of obtaining
the representative consensus for two different mixture scen-
arios and a range of numbers of molecules sampled (i.e. clone
colonies picked). Our results relate only to obtaining the most
abundant sequence. We need other information (e.g. effect-
ively applied extraction and PCR controls, phylogenetic plaus-
ibility, etc.) to decide whether this most abundant sequence is
an authentic aDNA.
In the ﬁrst scenario (Figure 1a), we assumed that the correct
nucleotide at a site is mixed with a single other nucleotide.
The probability of obtaining the representative consensus for
a given proportion of the correct nucleotide in the template
increases (or at least does not decrease) as the number of
clones increases, provided the correct nucleotide has a fre-
quency >50%. For example, if the correct nucleotide has a
frequency of 70% and the incorrect nucleotide has a frequency
of 30%, then the chance of obtaining the representative
consensus is 90% with 10 clones and 97% with 20 clones.
If the correct nucleotide is mixed with three other nucle-
otides having equal frequencies (Figure 1b), the probability of
obtaining the representative consensus is higher because each
of the incorrect nucleotides is less common. If the correct
nucleotide has a frequency of 70% and each incorrect nucle-
otide has a frequency of 10%, the probability of obtaining
the representative consensus is 98% with 10 clones and
>99% with 20 clones. In this case, the probability of obtaining
the representative consensus increases (or at least does not
decrease) with the number of clones as long as the correct
nucleotide has a frequency >25%. Thus, we may have a reas-
onable chance of obtaining the representative consensus even
with high rates of contamination and damage. For example,
if the correct nucleotide has a frequency of 40% and the three
incorrect nucleotides each have a frequency of 20%, the
chance of getting the representative consensus is 62% from
10 clones or 75% from 20 clones.
In principle, we could use Equation 3 to determine the
probability that we have obtained the representative consensus
Figure 1. The probability of obtaining the representative consensus when the initial template contains: (a) a mixture of the correct nucleotide and one other;
(b) a mixture of the correct nucleotide and three others, with the three incorrect nucleotides having equal frequency. PC is the frequency of the correct nucleotide,
andnis thenumberofmoleculessampledtoform theconsensus.Thelinesaresmoothedcontoursoftheprobability ofobtainingtherepresentative consensusbeing
90% (solid line), 75% (dashed line) or 50% (dotted line).
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abilities PC, PI1, PI2 and PI3 exactly, so we would have to
integrate over all possible values of these. A simpler approach
is to use the approximate conﬁdence intervals for multinomial
proportions developed by Goodman (21). The 100 (1   a)%
conﬁdence interval for the ith kind of molecule out of k
different kinds is
½B þ 2ni – BBþ 4ni N   ni ðÞ =N ðÞ ðÞ
1=2 = 2 N þ B ðÞ ½  ‚ 4
where N is the number of molecules sampled, ni is the number
ofthese that were ofthe ith kind, and Bis the upper 100 (a/k)th
percentile of the c
2 distribution with one degree of freedom.
If we were looking at the distribution of nucleotides at a single
site, k would be 4. The Goodman (21) conﬁdence intervals are
approximate, and may not be very reliable for small samples.
Nevertheless, they are simple to calculate. Better but more
complicated intervals exist (22). We conducted a number of
Monte Carlo simulations and found that the Goodman inter-
vals generally work well for large samples, but do not work
well for fewer than 12 samples.
Goodman (21) also shows how to calculate approximate
simultaneous conﬁdence intervals for all pairwise differences
between proportions. For the most abundant molecule in
the sample, all these differences will be positive. If the 100
(1   a)% conﬁdence intervals for all these differences do not
include zero, then one or more of these differences will be
negative (we will have wrongly identiﬁed the consensus) no
more than 100a% of the time. The conﬁdence intervals are
dij – ½Cðpi þ pj   d2
ijÞ=N 
1=2‚ 5
where dij is pi   pj, pi is the proportion of observations falling
in category i, C is the upper 100 (a/K)th percentile of the c2
distribution with one degree of freedom, and K = k(k   1)/2.
For example, if we take a sample of 10 clones and observe 7
molecules of type 1 and one each of three other types, then the
95% conﬁdence intervals on the proportions are [0.3289,
0.9174] for the type of molecule we observed seven times,
and [0.0124, 0.4949] forthe three types we observedonce.The
lower 95% conﬁdence limit for the difference between the
proportions of the type of molecule we observed seven times
and each of the other types of molecule is 0.0466. Thus, we
would expect to identify the representative consensus >95% of
the time. On the other hand, if we observed seven molecules of
type 1, 3 of type 2, and none of types 3 or 4, the 95% con-
ﬁdenceintervalsontheproportionswouldbe[0.3289,0.9174],
[0.0826, 0.6711], [0, 0.3842] and [0, 0.3842], respectively.
The lower 95% conﬁdence limits for the differences between
theproportionsofthetypeofmoleculeweobservedeighttimes
and the types of molecule we observed 2, 0 and 0 times are
 0.0674, 0.4663 and 0.4663, respectively. We would expect
to identify the representative consensus <95% of the time. If
we observed the sameproportions,but doubled the sample size
(giving 16, 4, 0 and 0 observations), the lower 95% conﬁdence
limits for the differences in proportions between the most
abundant type of molecule and each other type would be
0.1281, 0.5640 and 0.5640. Thus, either a larger sample or
a less even distribution of molecules among types increases
our conﬁdence that the consensus is really the most abundant
type of molecule.
If we take a single site, we will have wrongly identiﬁed the
consensus <5% of the time if all the three lower 95% conﬁd-
ence limits do not include zero. However, when we have 40 nt
positions in a sequence, we would expect to have two wrong
consensus positions on average, even if all the lower 95%
conﬁdence limits are positive. A simple way to avoid this
problem is to use a more conservative signiﬁcance level,
a/s (s: sequence length), for each nucleotide position. This
gives us a conservative estimate for the probability that we
have identiﬁed the representative sequence as a whole. We
may needslightlymoreclonestohaveasigniﬁcant resultatthe
sequence level. Forexample, ifwe had 20 clones ofa sequence
with 40 nt and observed the same proportions as above (i.e. 16,
4, 0 and 0), one of the lower 95% conﬁdence limits would be
negative. However, if we had 25 clones (20, 5, 0 and 0), all the
95% conﬁdence limits would be positive.
RECOMMENDATIONS: A FIVE STEP STRATEGY
Sequence at least 12 clones from each PCR
amplification
The number of clones the researcher chooses to sequence is a
trade-off between expense and the minimum number required
for appropriate statistical treatment. Based on our simulations
using the Goodman equation, we recommend that in the ﬁrst
instance a minimum number of 12 clones are sequenced to
create a consensus sequence for each PCR product of interest.
Cloning is the only way to elucidate the extent of template
mixtureaseachclonedbacterialcolonyrepresentsthesequence
ofa singlePCR amplicon. Comparing the sequences of a given
number of single-amplicon colonies and forming a consensus
sequencefromthemisagoodwaytogetanaccurateconsensus
sequence where the template is mixed (sequencing each clone
more than once would be slightly more accurate). Cloning has
some disadvantages. Besides being time-consuming and
expensive, each clone replicates a single DNA molecule and
thusonlyasmallnumberofmoleculesaresampled(20colonies
picked=20templatemoleculesorfewer).Therefore,itisessen-
tial to sample and sequence a sufﬁcient number of cloned col-
onies to have a good chance of obtaining the representative
consensus.Takingaconsensusoftoofewcloneshasthepoten-
tial for higher error rates than simply direct sequencing [e.g.
some researchers sequence only two clones (23)].
We can put a conﬁdence interval on the probability that our
consensuschoice isanaccurate reﬂection ofthemostabundant
sequence present in the template mixture. This conﬁdence
level decreases as the relative frequency of the most abundant
nucleotide decreases, i.e. the greater the mixture, the lower the
probability of discovering the most abundant sequence. The
number of clones needed to attain a given level of conﬁdence
intheconsensusdependsontheextentofthe templatemixture,
which is unknown until sequencing of clones has begun.
Enter the clone sequence data in the Consensus
Confidence program and calculate the confidence
levels for the consensus sequence
The percentage conﬁdence levels of the consensus sequence
from the selected clones can be simply and swiftly calculated
using our Consensus Conﬁdence program, which can be found
at http://www.mcdonald.cam.ac.uk (Figure 2). Sequence data
2552 Nucleic Acids Research, 2005, Vol. 33, No. 8Figure 2. The Consensus Confidence program (http://www.mcdonald.cam.ac.uk) showing three dialogue boxes: the data input box, the results box and the details
box.To use, cut and paste pre-alignedsequence data with a five character sequence identifierfrom a text file or Word documentand clickOK to run the calculation
(basedonEquations4and5).Theresults(aconsensussequence,confidencelevelsforeachnucleotideandawholesequenceconfidencelevel)canbecopiedbackinto
a text file or Word document if required. For full details on how to use the Consensus Confidence program, please consult the help files, which can be found on the
webpage.
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from a text or word ﬁle (the program allows a ﬁve character
sequence identiﬁer of your choice). The program requires
sequences from at least 10 clones to function accurately for
the reasons stated above, and the system will easily analyse up
to 100 sequences, of a length up to 800 nt. For full details of
how to use the Consensus Conﬁdence program, please refer to
the help ﬁles.
The Consensus Conﬁdence program constructs a consensus
sequence based on the input clone sequences and calculates a
percentage probability that each individual nucleotide position
occurs statistically most frequently with a conﬁdence level
between 70% and 95% using Equations 4 and 5 above. Addi-
tionally, the program estimates the probability that we have
identiﬁedtherepresentativesequenceasawholebycalculating
the 100 (1   a/s)% lower conﬁdence limits for the difference
(s: sequence length, a=0.05) for each nucleotide position.
Figure 3a shows the Consensus Conﬁdence program’s cal-
culation of the conﬁdence levels for the consensus sequence
derivedfrom20clonesfromtwoPCRs oftheNeanderthaltype
specimen [data from Figure 1, (24)]. As can be seen, 2 nt
positions have <70% conﬁdence levels [positions 00132
and 00141 of the Hyper-variable region II of the mitochondrial
D-loop, numbering according to Anderson et al. (25)]. In this
case, more clone sequences need to be added to resolve the
ambiguous nucleotide positions (Figure 3b).
In ambiguous situations how many additional clones should
be sequenced in total? Statistically there is no upper limit but
practicality and experience suggests a limit of 30 clones. If 30
clones are insufﬁcient to resolve a particular nucleotide posi-
tion at >95% conﬁdence, then the most abundant nucleotide at
that position should be accepted, but highlighted in any pub-
lication as having a low conﬁdence level, with the alternative
nucleotide(s) and conﬁdence level(s) published alongside. If
the position of the doubtful nucleotide falls at a point mutation
that is phylogenetically signiﬁcant, this consensus sequence
should not be included in any phylogenetic analysis, as any
inference will be based on weak data. In Figure 3b, 10 addi-
tional clone sequences have been added to the conﬁdence level
calculation for the region encompassing the ambiguous
nucleotide positions. The results show that the ambiguous
nucleotide positions have been resolved to a 95% conﬁdence
level, although the sequence level signiﬁcance is still <95% at
one position [position 00141 (25), where in the 30 clones input
there are 23 Cs and 7 Ts at that position].
Although we would expect to have the highest conﬁdence
levels in the consensus sequences we publish (e.g. 95% or
more), if the result is of particular importance or interest it
may be appropriate to publish it, even if the conﬁdence levels
are lower (e.g. 80% or less) as long as this conﬁdence level
is reached by an appropriate number of clones (say, at least
30 per PCR) and that the result and any interpretation arising
from it is tempered with due caution.
Apply the standard range of external criteria for
validating the nature of your consensus sequence
Comparing cloned colonies from a single PCR is clearly insuf-
ﬁcienttoauthenticatetheendogeneityoftheaDNAtemplateof
a given sample. The Consensus Conﬁdence program will only
allow the researcher to assess the conﬁdence levels of the con-
sensus sequence for each given PCR. Therefore, having iden-
tiﬁed the most abundant amplicon in a given PCR in step 2, the
user then needs to determine whether its sequence is truly an
aDNA, a modern contaminant, or the product of misincor-
poratednucleotidesresultingfromseverelydamagedtemplate.
Figure 3. WeinputpublishedclonesequencesfortheHVIIregionoftheNeanderthaltypespecimen[Figure1(24)]intotheConsensusConfidenceprogram[clones
B18.1–B18.13 and D20.1–D20.7; a total of 20 clone sequences, covering nucleotide positions 00124–00201, numbering after Anderson et al. (25)]. (a) The results
show2ntpositionswheretheconfidencelevelofthatparticularnucleotiderepresentingthemostabundantoneinthePCRwas<95%[nucleotidepositions00132and
00141(25),hereshownasposition9and18].(b)Weaddedtheadditionalclonesequenceswhichoverlaptheambiguous(lowconfidencelevel)nucleotidepositions
so that the total number of clones was 30 [C19.1–C19.2, nucleotide positions 00124–00149 (25)]. The results show that the confidence levels for the ambiguous
nucleotide positions are now at 95%, although the sequence level confidence is still <95%.
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applied to make the case that the consensus sequence gained
is indeed more likely than not to be the authentic endogenous
DNA of the ancient sample in question. We refer the reader to
acomprehensivelist ofprotocols andrecommendations forthe
authentication of aDNA available in the literature: the effect-
ive use of negative controls (20), quantiﬁcation, replication of
results, both by the primary researcher and by an external
laboratory (18) blind testing (17), amelogenin sex versus mor-
phological sex(19).Nodoubt,advancesinaDNA research and
technology will uncover more efﬁcient and more powerful
endogenous DNA validation tools in the future.
Report the number of clones and the confidence
levels of your published consensus sequence
Ourrecommendationtoincludetheindividualclonesequences
and their conﬁdence levels in a publication should be self-
evident. However, in reviewing the literature, we sometimes
found it difﬁcult to ascertain the number of clones that made
up the published consensus sequences and what the extent
of template mixture was (26,27). Given that we have argued
that template mixture is almost unavoidable, greater transpar-
ency would be welcome if we are to judge each other’s work
effectively (28).
Report all the factors that might contribute to or
minimize the probability of template mixture occurring
All the factors that might contribute to or minimize the prob-
ability of template mixture occurring (e.g. probable extent of
contamination and use of cloning to identify template mixture)
should be recorded. For example, Willerslev and co-workers
(29) outline very carefully the care they took to understand the
full extent of the template mixture from which they derived
their ﬁnal sequences. This is particularly important where
aDNA is being used to address large and signiﬁcant research
questions or where the research claims are potentially contro-
versial (such as the relationship between Neanderthals and
modern humans, or the analysis of forensic specimens).
CONCLUSION
It is probably not technically feasible to guarantee that the
aDNA sequences we publish are completely error free and this
has to be understood and accepted (30). Therefore, we should
consider that our results come with given levels of conﬁdence
derived from a range of factors, from the taphonomy and
preservation history of the artefact and the micro-taphonomy
of each extracted aDNA molecule, to excavation and post-
excavation handling and laboratory protocols. Many of these
conﬁdence levels are impossible to quantify accurately. How-
ever, the simulations we have carried out and the Consensus
Conﬁdence program presented here allow the conﬁdence level
of the ﬁnal consensus sequence to be accurately assessed.
We stress again that the Consensus Conﬁdence program
assesses the quality of the consensus sequence derived from
a given PCR, it does not verify whether that consensus seq-
uence is an authentic aDNA and cannot replace the use of
standard aDNA authentication methods. It should be used in
conjunction with the accepted authentication methods, which
must be employed if the authenticity and endogeneity of the
resulting consensus sequences is to be argued. By using a
wide array of authentication methods, the aDNA researcher
must build a case that allows them to argue that the aDNA
sequences published are more likely to be authentic and endo-
genous than not. Unfortunately, we will never be able to state
unequivocally that our sequences are 100% guaranteed to be
authentic, and we should not try to do this. However, one
should use all appropriate methods to increase the probability
that the DNA is an authentic aDNA. Our methods allow one to
state that the consensus sequence is the representative of the
total amplicon populationinagivenPCR, andisthus, however
valuable, only one small step in the authentication process.
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